GlassScriptPhysician profile
Errol Inci
NPI 1750734349
$95,730.17
in general payments reported to CMS, 2019-2025
12 companies · $501 in 2025
The $501 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $138 · 2021: $12K · 2022: $1,132 · 2023: $22K · 2024: $60K · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $75K · Food and Beverage: $4,132 · Travel and Lodging: $4,080 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $74,574.90 |
| Food and Beverage | $4,131.54 |
| Travel and Lodging | $4,079.73 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $59,213.34 | 2022-2025 | Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $21,798.92 | 2021-2025 | Mitraclip |
| Medtronic, INC. | $12,196.22 | 2022-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $671.30 | 2021-2025 | Rotapro, Stingray, Synergy |
| W. L. Gore & Associates, INC. | $531.78 | 2022-2024 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $404.91 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Asahi Intecc USA, INC. | $244.27 | 2020-2021 | |
| Teleflex LLC | $208.11 | 2022-2023 | Turnpike |
| Abiomed | $173.39 | 2021 | |
| Inari Medical, INC. | $166.96 | 2022 | |
| Cardiva Medical, INC. | $101.78 | 2021 | |
| Medtronic Vascular, INC. | $19.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Errol Inci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.